Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 144 results.
User Information
Export Records
  1. 1.   Rare germline variants in known melanoma susceptibility genes in familial melanoma
  2. Goldstein, Alisa M.; Xiao, Yanzi; Sampson, Joshua; Zhu, Bin; Rotunno, Melissa; Bennett, Hunter; Wen, Yixuan; Jones, Kristine; Vogt, Aurelie; Burdette, Laurie; Luo, Wen; Zhu, Bin; Yeager, Meredith; Hicks, Belynda; Han, Jiali; De Vivo, Immaculata; Koutros, Stella; Andreotti, Gabriella; Beane-Freeman, Laura; Purdue, Mark; Freedman, Neal D.; Chanock, Stephen J.; Tucker, Margaret A.; Yang, Xiaohong R.
  3. Human Molecular Genetics. 2017, Dec 15; 26(24): 4886-4895.
  1. 2.   Analysis of the ABCA4 Gene by Next-Generation Sequencing
  2. Zernant, J.; Schubert, C.; Im, K. M.; Burke, T.; Brown, C. M.; Fishman, G. A.; Tsang, S. H.; Gouras, P.; Dean, M.; Allikmets, R.
  3. Investigative Ophthalmology & Visual Science. 2011, Oct; 52(11): 8479-8487.
  1. 3.   Structure and function of RapA: A bacterial Swi2/Snf2 protein required for RNA polymerase recycling in transcription
  2. Jin, D. J.; Zhou, Y. N.; Shaw, G.; Ji, X. H.
  3. Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms. 2011, Sep; 1809(9): 470-475.
  1. 4.   Killer Immunoglobulin-Like Receptor Transcriptional Regulation: A Fascinating Dance of Multiple Promoters
  2. Cichocki, F.; Miller, J. S.; Anderson, S. K.
  3. Journal of Innate Immunity. 2011, Apr; 3(3): 242-248.
  1. 5.   Evolution of domain promiscuity in eukaryotic genomes-a perspective from the inferred ancestral domain architectures
  2. Cohen-Gihon, I.; Fong, J. H.; Sharan, R.; Nussinov, R.; Przytycka, T. M.; Panchenko, A. R.
  3. Molecular Biosystems. 2011, Mar 1; 7(3): 784-792.
  1. 6.   Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
  2. Dowdell, K. C.; Niemela, J. E.; Price, S.; Davis, J.; Hornung, R. L.; Oliveira, J. B.; Puck, J. M.; Jaffe, E. S.; Pittaluga, S.; Cohen, J. I.; Fleisher, T. A.; Rao, V. K.
  3. Blood. 2010, Jun; 115(25): 5164-5169.
  1. 7.   Hematologically important mutations: The autosomal recessive forms of chronic granulomatous disease (second update)
  2. Roos, D.; Kuhns, D. B.; Maddalena, A.; Bustamante, J.; Kannengiesser, C.; de Boer, M.; van Leeuwen, K.; Koker, M. Y.; Wolach, B.; Roesler, J.; Malech, H. L.; Holland, S. M.; Gallin, J. I.; Stasia, M. J.
  3. Blood Cells Molecules and Diseases. 2010, Apr; 44(4): 291-299.
  1. 8.   Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)
  2. Rao, V. K.; Price, S.; Perkins, K.; Aldridge, P.; Tretler, J.; Davis, J.; Dale, J. K.; Gill, F.; Hartman, K. R.; Stork, L. C.; Gnarra, D. J.; Krishnamurti, L.; Newburger, P. E.; Puck, J.; Fleisher, T.
  3. Pediatric Blood & Cancer. 2009 52(7): 847-852.
  1. 9.   The signatures of autozygosity among patients with colorectal cancer
  2. Bacolod, M. D.; Schemmann, G. S.; Wang, S.; Shattock, R.; Giardina, S. F.; Zeng, Z. S.; Shia, J. R.; Stengel, R. F.; Gerry, N.; Hoh, J.; Kirchhoff, T.; Gold, B.; Christman, M. F.; Offit, K.; Gerald, W. L.; Notterman, D. A.; Ott, J.; Paty, P. B.
  3. Cancer Research. 2008 68(8): 2610-2621.
  1. 10.   Identification and characterization of a novel folliculin-interacting protein FNIP2
  2. Hasumi, H.; Baba, M.; Hong, S. B.; Hasumi, Y.; Huang, Y.; Yao, M.; Valera, V. A.; Linehan, W. M.; Schmidt, L. S.
  3. Gene. 2008 415(1-2): 60-67.
  1. 11.   Comparison of the rapidly evolving KIR locus in Parsis and natives of India
  2. Kulkarni, S.; Single, R. M.; Martin, M. P.; Rajalingam, R.; Badwe, R.; Joshi, N.; Carrington, M.
  3. Immunogenetics. 2008 60(3-4): 121-129.
  1. 12.   Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection
  2. Pascal, V.; Yamada, E.; Martin, M. P.; Alter, G.; Altfeld, M.; Metcalf, J. A.; Baseler, M. W.; Adelsberger, J. W.; Carrington, M.; Anderson, S. K.; McVicar, D. W.
  3. Journal of Immunology. 2007, Aug; 179(3): 1625-1633.
  1. 13.   Slicing a protease: Structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domains
  2. Rotanova, T. V.; Botos, I.; Melnikov, E. E.; Rasulova, F.; Gustchina, A.; Maurizi, M. R.; Wlodawer, A.
  3. Protein Science. 2006, Aug; 15(8): 1815-1828.
  1. 14.   Identification of the ancestral killer immunoglobulin-like receptor gene in primates
  2. Sambrook, J. G.; Bashirova, A.; Andersen, H.; Piatak, M.; Vernikos, G. S.; Coggill, P.; Lifson, J. D.; Carrington, M.; Beck, S.
  3. Bmc Genomics. 2006, Aug; 7
  1. 15.   Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection
  2. Si, Z. H.; Vandegraaff, N.; O'HUigin, C.; Song, B.; Yuan, W.; Xu, C.; Perron, M.; Li, X.; Marasco, W. A.; Engelman, A.; Dean, M.; Sodroski, J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, MAY 9; 103(19): 7454-7459.
  1. 16.   RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi
  2. Lee, D.; Walsh, J. D.; Mikhailenko, I.; Yu, P.; Migliorini, M.; Wu, Y. B.; Krueger, S.; Curtis, J. E.; Harris, B.; Lockett, S.; Blacklow, S. C.; Strickl, D. K.; Wang, Y. X.
  3. Molecular Cell. 2006, MAY 5; 22(3): 423-430.
  1. 17.   Mutations in the gene encoding the low-density lipoprotein receptor LRP4 cause abnormal limb development in the mouse
  2. Simon-Chazottes, D.; Tutois, S.; Kuehn, M.; Evans, M.; Bourgade, F.; Cook, S.; Davisson, M. T.; Guenet, J. L.
  3. Genomics. 2006, MAY; 87(5): 673-677.
  1. 18.   Proteomic characterization of lipids rafts markers from the rat intestinal brush border
  2. Nguyen, H. T. T.; Amine, A. B.; Lafitte, D.; Waheed, A. A.; Nicoletti, C.; Villard, C.; Letisse, M.; Deyris, V.; Roziere, M.; Tchiakpe, L.; Danielle, C. D.; Comeau, L.; Hiol, A.
  3. Biochemical and Biophysical Research Communications. 2006, MAR 31; 342(1): 236-244.
  1. 19.   Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice
  2. Chiang, Y. J.; Nguyen, M. L.; Gurunathan, S.; Kaminker, P.; Tessarollo, L.; Campisi, J.; Hodes, R. J.
  3. Molecular and Cellular Biology. 2006, MAR; 26(6): 2037-2043.
  1. 20.   Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan
  2. Yang, X. H. R.; Goldstein, A. M.; Chen, C. J.; Rabkin, C. S.; Chen, J. Y.; Cheng, Y. J.; Hsu, W. L.; Sun, B.; Diehl, S. R.; Liu, M. Y.; Walters, M.; Shao, W.; Ortiz-Conde, B. A.; Whitby, D.; Elmore, S. H.; Gulley, M. L.; Hildesheim, A.
  3. International Journal of Cancer. 2006, MAR 1; 118(3): 780-784.
  1. 21.   Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors
  2. Nanda, A.; Karim, B.; Peng, Z. S.; Liu, G. S.; Qiu, W. P.; Gan, C.; Vogelstein, B.; St Croix, B.; Kinzler, K. W.; Huso, D. L.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, FEB 28; 103(9): 3351-3356.
  1. 22.   Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III
  2. Gan, J. H.; Tropea, J. E.; Austin, B. P.; Court, D. L.; Waugh, D. S.; Ji, X. H.
  3. Cell. 2006, JAN 27; 124(2): 355-366.
  1. 23.   Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
  2. Rothman, N.; Skibola, C. F.; Wang, S. S.; Morgan, G.; Lon, Q.; Smith, M. T.; Spinelli, J. J.; Willett, E.; De Sanjose, S.; Cocco, P.; Berndt, S. I.; Brennan, P.; Brooks-Wilson, A.; Wacholder, S.; Becker, N.; Hartge, P.; Zheng, T. Z.; Roman, E.; Holly, E. A.; Boffetta, P.; Armstrong, B.; Cozen, W.; Linet, M.; Bosch, F. X.; Ennas, M. G.; Holford, T. R.; Gallagher, R. P.; Rollinson, S.; Bracci, P. M.; Cerhan, J. R.; Whitby, D.; Moore, P. S.; Leaderer, B.; Lai, A.; Spink, C.; Davis, S.; Bosch, R.; Scarpa, A.; Zhang, Y. W.; Severson, R. K.; Yeager, M.; Chanock, S.; Nieters, A.
  3. Lancet Oncology. 2006, JAN; 7(1): 27-38.
  1. 25.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel